Fundraising Fox

Earli

South San Francisco, US · Founded 2018 · Delaware corporation · 7 known investors

earli.com ↗

Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devicesin /earli@goearli

Founders & leadership

DS
Dr. Sam GambhirFounder
CRCyriac Roeding
Cyriac RoedingCo-founder
DD
Dr. David SuhyCo-founder & Chief Scientific Officer
JK
Justin KaoDirector
JC
Jorge CondeDirector

Investors · 7

Andreessen HorowitzMenlo Park · $500K – $50M
Breyer CapitalAustin · $500K – $10M
Han River Partners
Menlo VenturesSan Francisco · $1M – $20M
Think.HealthBerlin · $550K – $11M
DFJreportedSan Mateovia Justin Kao · board
MBX CapitalreportedClaymont · $250K – $2.5M

Reported raises · per SEC filings

Form D private placements
▶$40MraisedJan 2021 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Justin KaoDirector
  • Jorge CondeDirector
  • Cyriac RoedingExecutive Officer, Director
  • David SuhyExecutive Officer, Director
Offering amount
$40M
Amount sold
$40M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.